We are the champions!
Release time:
2023-06-07
To celebrate the 30th anniversary of the listing of the peak, the group company's labor union held a two-day basketball game. Eight teams from various enterprises of the company competed fiercely, and finally our Huang Ping Jianfeng basketball team won the championship with a record of four wins in four games!
As the youngest peak enterprise, our Huang Ping peak selected elite soldiers to form the team. There are not only young people who have recently joined the team, but also old spikes with more than ten or twenty years of service. Everyone rushed from Huang Ping to Jinhua to participate in the competition, not only to achieve good results, but also to strengthen communication with brother companies and show Huang Ping. The team image of the peak.
After the start of the competition, the eight teams were divided into two groups for the group stage. All our team members worked together to advance all the way, qualifying for the first place in the group with a total victory record, and advancing to the finals with our heads held high. The
championship and runner-up finals were launched between Huang Ping's peak and Daye's peak. At the scene of the game, the players of both sides were full of energy, precise long-range shots, tacit pick-and-roll, flexible breakthroughs, and exquisite passes were staged from time to time. The brotherly teams that have finished the schedule gathered at the scene to cheer for us, cheer for each of our goals, and constantly push the atmosphere of the stadium to a climax.
With the final whistle sounded, the score was fixed. Our Huang Ping Peak Basketball Team lived up to expectations and won the championship trophy.
For employees of foreign companies, this competition is a rare opportunity to learn about the peaks and communicate with brother companies. Because of this, the group company specially arranged a small "program" for us to visit the peak building of the group headquarters and learn about the development process of the peak. This allows us to further understand the corporate culture of the peak, and a deeper understanding of the peak spirit of "aspiring to the top and climbing the peak forever. Stadium competition requires every team member to be uplifted and determined to be the top. In the work, we need every peak employee to be uplifted and determined to be the top, to devote themselves to the work with strong physique and full energy, and strive to create new performance. Achieve new breakthroughs and climb one peak after another! (Wang Lixian)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31